Clinical Trial Update: Peripheral Dopamine in Postural Tachycardia Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial on peripheral dopamine for Postural Tachycardia Syndrome/Orthostatic Intolerance has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthostatic Intolerance
• Postural Tachycardia Syndrome

Snippet

Sponsor: Vanderbilt University | Conditions: Postural Tachycardia Syndrome, Orthostatic Intolerance | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-09-20